ÂÜÀòÂÒÂ×

The Scientific Research and Development team at Skyhawk Therapeutics focuses on the discovery and optimization of small molecules that correct RNA splicing and mis-splicing. Leveraging proprietary kinetic, structural, and computational models, this multidisciplinary team advances drug development efforts across various disease areas by conducting high-throughput screening, biochemical and cellular assays, and preclinical studies to ensure the efficacy and safety of potential therapeutics.